← Back
Data updated: Mar 10, 2026
ANTIBIOTICE
Infectious DiseaseGastroenterologyDermatology
ANTIBIOTICE is a generic drug manufacturer focused on Infectious Disease, Gastroenterology, Dermatology.
2009
Since
3
Drugs
-
Trials
44
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-01-30
Labeling
AMPICILLIN AND SULBACTAM 2026-01-27
Labeling
AMPICILLIN AND SULBACTAM 2026-01-19
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 60%
3 drugs
Gastroenterology 20%
1 drugs
Dermatology 20%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Dermatology
CASPER PHARMA LLC big-pharma
Infectious Disease, Gastroenterology, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology
Discontinued (0)
Company Info
- First Approval
- 2009-12-28
- Latest
- 2024-09-27
- Applications
- 3